Author

F. Korkmaz

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Pharmacology & Toxicology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 2 Organism:mouse· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Organism:human· 1 Organism:non-human primate· 1

Frequent Co-Authors

D. Lizneva· 3 shared M. Zaidi· 3 shared T. Yuen· 3 shared A. A. Gumerova· 2 shared A. Macdonald· 2 shared C. J. Rosen· 2 shared D. Sant· 2 shared F. Sultana· 2 shared

Activity by Year

2022-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersPhysiology

D. Lizneva

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Single Transcript Level Atlas of Oxytocin and the Oxytocin Receptor in the Mouse Brain

V. Ryu, A. A. Gumerova, G. Pevnev, F. Korkmaz, H. Kannangara, L. Cullen, R. Witztum, S. L. Sims, T. Frolinger, O. Moldavski, O. Barak, J. J. Cao, D. Lizneva, K. A. Goosens, T. Yuen, M. Zaidi

The paper maps OXT and OXTR expression in the mouse brain at the single transcript level to identify functional OXT nodes.

eLife · Feb 23, 2026Peer-reviewedPhysiology

Development and Biophysical Characterization of a Humanized FSH-Blocking Monoclonal Antibody Therapeutic Formulated at an Ultra-High Concentration

S. Rojekar, A. R. Pallapati, J. Gimenez-Roig, F. Korkmaz, F. Sultana, D. Sant, C. M. Haeck, A. Macdonald, S.-M. Kim, C. J. Rosen, O. Barak, M. Meseck, J. Caminis, D. Lizneva, T. Yuen, M. Zaidi

This paper develops a stable, high-concentration formulation of a humanized FSH-blocking antibody and validates its physicochemical and thermal stability.

eLife · Jun 19, 2023Peer-reviewedBioengineering

A Single Multipurpose FSH-Blocking Therapeutic for Osteoporosis and Obesity

S. Gera, T.-C. Kuo, F. Korkmaz, D. Sant, V. DeMambro, A. A. Gumerova, K. Sudha, A. Padilla, G. Prevot, J. Munitz, A. Teunissen, M. M. T. van Leent, T. G. J. M. Post, J. C. Fernandes, J. Netto, , M. Zaidi

This paper develops and tests a first-in-class FSH-blocking antibody, MS-Hu6, showing efficacy in preventing obesity and osteoporosis in mice and safety in monkeys.

bioRxiv · Feb 28, 2022 · PreprintPharmacology & Toxicology